StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)

Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%

West Pharmaceutical Services total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

West Pharmaceutical Services's total debt was $202.90M at Sep 30, 2026. For fiscal 2025 it was $202.80M, up 0.1% from the year before. Over ten years it grew -3.8% a year on average. The highest annual figure on record is $411.50M in fiscal 2012.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$202.80M+0.1%
FY2024Dec 31, 2024$202.60M-2.0%
FY2023Dec 31, 2023$206.80M-1.0%
FY2022Dec 31, 2022$208.90M-17.4%
FY2021Dec 31, 2021$253.00M-0.9%
FY2020Dec 31, 2020$255.20M-0.8%
FY2019Dec 31, 2019$257.30M+31.2%
FY2018Dec 31, 2018$196.10M-0.5%
FY2017Dec 31, 2017$197.00M-13.8%
FY2016Dec 31, 2016$228.60M-23.3%
FY2015Dec 31, 2015$298.20M-11.1%
FY2014Dec 31, 2014$335.50M-10.2%
FY2013Dec 31, 2013$373.50M-9.2%
FY2012Dec 31, 2012$411.50M+17.8%
FY2011Dec 31, 2011$349.40M-2.5%
FY2010Dec 31, 2010$358.40M-5.6%
FY2009Dec 31, 2009$379.60M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$202.90M+0.1%
Q2 FY2026Jun 30, 2026$202.90M+0.1%
Q1 FY2026Mar 31, 2026$202.80M+0.1%
Q4 FY2025Dec 31, 2025$202.80M+0.1%
Q3 FY2025Sep 30, 2025$202.70M+0.0%
Q2 FY2025Jun 30, 2025$202.60M-1.6%
Q1 FY2025Mar 31, 2025$202.60M-1.7%
Q4 FY2024Dec 31, 2024$202.60M-2.0%
Q3 FY2024Sep 30, 2024$202.60M-2.3%
Q2 FY2024Jun 30, 2024$205.80M-1.0%
Q1 FY2024Mar 31, 2024$206.20M-1.0%
Q4 FY2023Dec 31, 2023$206.80M-1.0%
Q3 FY2023Sep 30, 2023$207.30M-1.0%
Q2 FY2023Jun 30, 2023$207.80M-17.5%
Q1 FY2023Mar 31, 2023$208.30M-17.5%
Q4 FY2022Dec 31, 2022$208.90M-17.4%
Q3 FY2022Sep 30, 2022$209.40M-17.6%
Q2 FY2022Jun 30, 2022$252.00M-0.8%
Q1 FY2022Mar 31, 2022$252.50M-0.8%
Q4 FY2021Dec 31, 2021$253.00M-0.9%
Q3 FY2021Sep 30, 2021$254.10M-0.6%
Q2 FY2021Jun 30, 2021$254.10M-0.8%
Q1 FY2021Mar 31, 2021$254.60M-0.8%
Q4 FY2020Dec 31, 2020$255.20M-0.8%
Q3 FY2020Sep 30, 2020$255.70M+31.1%
Q2 FY2020Jun 30, 2020$256.20M+30.7%
Q1 FY2020Mar 31, 2020$256.70M+31.3%
Q4 FY2019Dec 31, 2019$257.30M+31.2%
Q3 FY2019Sep 30, 2019$195.10M-0.6%
Q2 FY2019Jun 30, 2019$196.00M-0.2%
Q1 FY2019Mar 31, 2019$195.50M-1.3%
Q4 FY2018Dec 31, 2018$196.10M-0.5%
Q3 FY2018Sep 30, 2018$196.20M-14.6%
Q2 FY2018Jun 30, 2018$196.40M-14.4%
Q1 FY2018Mar 31, 2018$198.00M-13.4%
Q4 FY2017Dec 31, 2017$197.00M-13.8%
Q3 FY2017Sep 30, 2017$229.80M–
Q2 FY2017Jun 30, 2017$229.50M–
Q1 FY2017Mar 31, 2017$228.60M–
Q4 FY2016Dec 31, 2016$228.60M–

More West Pharmaceutical Services figures

See a number that looks wrong?